Join
Live feed
·
PRReleasevia Quantisnow
Icosavax Inc. logo

Icosavax Announces Positive Topline Interim Phase 1/1b Results for VLP Vaccine Candidate IVX-121 Against RSV

ByQuantisnow·Wall Street's wire, on your screen.
ICVX· Icosavax Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ICVX (Icosavax Inc.) and more on Quantisnow.